New York, NY -- (SBWire) -- 03/30/2018 --Overview

Hodgkin disease is a cancer of the lymphatic system. It usually starts in B lymphocytes. The disease can spread to nearby lymph nodes. Later it may spread to the lungs, liver or bone marrow. Signs and symptoms may include painless swelling of lymph nodes, fatigue, itching, night sweats, rapid weight loss and fever. Risk factors include age, family history, sex, history of Epstein-Barr infections. Treatment includes chemotherapy, radiation therapy, immunotherapy and stem cell transplant.

Click here for sample report @ http://www.wiseguyreports.com/sample-request/1773626-hodgkin-lymphoma-b-cell-hodgkin-lymphoma-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 27, 33, 9 and 1 respectively.

Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology).
- The pipeline guide reviews pipeline therapeutics for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
Table of Contents

Table of Contents 2
Introduction 5
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Overview 6
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Therapeutics Development 7
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Therapeutics Assessment 18
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Companies Involved in Therapeutics Development 30
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Drug Profiles 56
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Dormant Projects 399
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Discontinued Products 402
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Product Development Milestones 403
Appendix 417

List of Tables
Number of Products under Development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), H2 2017
Number of Products under Development by Companies, H2 2017
.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1773626-hodgkin-lymphoma-b-cell-hodgkin-lymphoma-pipeline-review-h2-2017

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.